Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Dancer perceptions of the cognitive, social, emotional, and physical benefits of modern styles of partnered dancing.

Lakes KD, Marvin S, Rowley J, Nicolas MS, Arastoo S, Viray L, Orozco A, Jurnak F.

Complement Ther Med. 2016 Jun;26:117-22. doi: 10.1016/j.ctim.2016.03.007. Epub 2016 Mar 9.

2.

The Pivotal Role of Aldehyde Toxicity in Autism Spectrum Disorder: The Therapeutic Potential of Micronutrient Supplementation.

Jurnak F.

Nutr Metab Insights. 2016 Jun 14;8(Suppl 1):57-77. doi: 10.4137/NMI.S29531. eCollection 2015.

3.

Investigation of folding of purified recombinant GRA1 protein using web based protein disorder servers and trypsin digestion.

Döşkaya M, Caner A, Değirmenci A, Jurnak F, Gürüz Y.

Protein Pept Lett. 2009;16(7):834-41.

PMID:
19601915
4.

WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.

Tang Y, Simoneau AR, Liao WX, Yi G, Hope C, Liu F, Li S, Xie J, Holcombe RF, Jurnak FA, Mercola D, Hoang BH, Zi X.

Mol Cancer Ther. 2009 Feb;8(2):458-68. doi: 10.1158/1535-7163.MCT-08-0885. Epub 2009 Jan 27.

5.

Discerning the Mauve factor, Part 2.

McGinnis WR, Audhya T, Walsh WJ, Jackson JA, McLaren-Howard J, Lewis A, Lauda PH, Bibus DM, Jurnak F, Lietha R, Hoffer A.

Altern Ther Health Med. 2008 May-Jun;14(3):56-62. Review.

PMID:
18517107
6.

Discerning the Mauve Factor, Part 1.

McGinnis WR, Audhya T, Walsh WJ, Jackson JA, McLaren-Howard J, Lewis A, Lauda PH, Bibus DM, Jurnak F, Lietha R, Hoffer A.

Altern Ther Health Med. 2008 Mar-Apr;14(2):40-50. Review. Erratum in: Altern Ther Health Med. 2008 May-Jun;14(3):15.

PMID:
18383989
7.
8.

GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine.

Döşkaya M, Kalantari-Dehaghi M, Walsh CM, Hiszczyńska-Sawicka E, Davies DH, Felgner PL, Larsen LS, Lathrop RH, Hatfield GW, Schulz JR, Gürüz Y, Jurnak F.

Vaccine. 2007 Feb 26;25(10):1824-37. Epub 2006 Nov 20.

PMID:
17234306
9.

Molecular complementarity between tetracycline and the GTPase active site of elongation factor Tu.

Heffron SE, Mui S, Aorora A, Abel K, Bergmann E, Jurnak F.

Acta Crystallogr D Biol Crystallogr. 2006 Nov;62(Pt 11):1392-400. Epub 2006 Oct 18.

PMID:
17057344
10.

Solving the structure of Escherichia coli elongation factor Tu using a twinned data set.

Heffron SE, Moeller R, Jurnak F.

Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):433-8. Epub 2006 Mar 18.

PMID:
16552145
12.

Resolving the space-group ambiguity of crystals of tomato fruit polygalacturonase.

Heffron S, Watkins S, Moeller R, Taban AH, Butowt R, DellaPenna D, Jurnak F.

Acta Crystallogr D Biol Crystallogr. 2003 Dec;59(Pt 12):2088-93. Epub 2003 Nov 27.

PMID:
14646066
13.

EF-Tu binding peptides identified, dissected, and affinity optimized by phage display.

Murase K, Morrison KL, Tam PY, Stafford RL, Jurnak F, Weiss GA.

Chem Biol. 2003 Feb;10(2):161-8.

14.

Characterization and implications of Ca2+ binding to pectate lyase C.

Herron SR, Scavetta RD, Garrett M, Legner M, Jurnak F.

J Biol Chem. 2003 Apr 4;278(14):12271-7. Epub 2003 Jan 22.

15.

GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.

Zuurmond AM, Martien de Graaf J, Olsthoorn-Tieleman LN, van Duyl BY, Mörhle VG, Jurnak F, Mesters JR, Hilgenfeld R, Kraal B.

J Mol Biol. 2000 Dec 15;304(5):995-1005.

PMID:
11124042
16.

Structure and function of pectic enzymes: virulence factors of plant pathogens.

Herron SR, Benen JA, Scavetta RD, Visser J, Jurnak F.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8762-9. Review.

18.

Structure of a plant cell wall fragment complexed to pectate lyase C.

Scavetta RD, Herron SR, Hotchkiss AT, Kita N, Keen NT, Benen JA, Kester HC, Visser J, Jurnak F.

Plant Cell. 1999 Jun;11(6):1081-92.

19.

Sequence profile of the parallel beta helix in the pectate lyase superfamily.

Heffron S, Moe GR, Sieber V, Mengaud J, Cossart P, Vitali J, Jurnak F.

J Struct Biol. 1998;122(1-2):223-35.

PMID:
9724624
20.

The tree-dimensional structure of aspergillus niger pectin lyase B at 1.7-A resolution.

Vitali J, Schick B, Kester HC, Visser J, Jurnak F.

Plant Physiol. 1998 Jan;116(1):69-80.

21.
22.

An alpha to beta conformational switch in EF-Tu.

Abel K, Yoder MD, Hilgenfeld R, Jurnak F.

Structure. 1996 Oct 15;4(10):1153-9.

23.

The Refined Three-Dimensional Structure of Pectate Lyase E from Erwinia chrysanthemi at 2.2 A Resolution.

Lietzke SE, Scavetta RD, Yoder MD, Jurnak F.

Plant Physiol. 1996 May;111(1):73-92.

24.
25.

Circular dichroism of the parallel beta helical proteins pectate lyase C and E.

Sieber V, Jurnak F, Moe GR.

Proteins. 1995 Sep;23(1):32-7.

PMID:
8539248
26.

Protein motifs. 3. The parallel beta helix and other coiled folds.

Yoder MD, Jurnak F.

FASEB J. 1995 Mar;9(5):335-42. Review.

PMID:
7896002
27.

Structure-based multiple alignment of extracellular pectate lyase sequences.

Heffron S, Henrissat B, Yoder MD, Lietzke S, Jurnak F.

Mol Plant Microbe Interact. 1995 Mar-Apr;8(2):331-4.

PMID:
7756698
28.

Functional implications of structure-based sequence alignment of proteins in the extracellular pectate lyase superfamily.

Henrissat B, Heffron SE, Yoder MD, Lietzke SE, Jurnak F.

Plant Physiol. 1995 Mar;107(3):963-76.

30.

Protein-protein interaction. Complex flexibility.

Jurnak F.

Nature. 1994 Dec 1;372(6505):409-10. No abstract available.

PMID:
7984232
31.

Parallel beta-domains: a new fold in protein structures.

Jurnak F, Yoder MD, Pickersgill R, Jenkins J.

Curr Opin Struct Biol. 1994 Dec;4(6):802-6. Review.

PMID:
7712282
32.

The Three-Dimensional Structure of Pectate Lyase E, a Plant Virulence Factor from Erwinia chrysanthemi.

Lietzke SE, Yoder MD, Keen NT, Jurnak F.

Plant Physiol. 1994 Nov;106(3):849-862.

33.

The ABC of EF-G.

Jurnak F.

Structure. 1994 Sep 15;2(9):785-8. Review.

PMID:
7812711
34.

Extension of the diffraction resolution of crystals.

Schick B, Jurnak F.

Acta Crystallogr D Biol Crystallogr. 1994 Jul 1;50(Pt 4):563-8.

PMID:
15299419
35.

Unusual structural features in the parallel beta-helix in pectate lyases.

Yoder MD, Lietzke SE, Jurnak F.

Structure. 1993 Dec 15;1(4):241-51.

PMID:
8081738
36.

New domain motif: the structure of pectate lyase C, a secreted plant virulence factor.

Yoder MD, Keen NT, Jurnak F.

Science. 1993 Jun 4;260(5113):1503-7.

PMID:
8502994
37.

An isotope edited classical Raman difference spectroscopic study of the interactions of guanine nucleotides with elongation factor Tu and H-ras p21.

Manor D, Weng GZ, Deng H, Cosloy S, Chen CX, Balogh-Nair V, Delaria K, Jurnak F, Callender R.

Biochemistry. 1991 Nov 12;30(45):10914-20.

PMID:
1932015
38.

Stabilization of the Escherichia coli elongation factor Tu-GTP-aminoacyl-tRNA complex.

Delaria K, Guillen M, Louie A, Jurnak F.

Arch Biochem Biophys. 1991 Apr;286(1):207-11.

PMID:
1897948
39.

Genetic engineering, isolation and characterization of a truncated Escherichia coli elongation factor Tu comprising domains 2 and 3.

Pieper U, Ehbrecht HJ, Fliess A, Schick B, Jurnak F, Pingoud A.

Biochim Biophys Acta. 1990 Oct 23;1087(2):147-56.

PMID:
2223877
40.

Three-dimensional models of the GDP and GTP forms of the guanine nucleotide domain of Escherichia coli elongation factor Tu.

Jurnak F, Heffron S, Schick B, Delaria K.

Biochim Biophys Acta. 1990 Aug 27;1050(1-3):209-14.

PMID:
2119811
41.
43.

Conformational changes involved in the activation of ras p21: implications for related proteins.

Jurnak F, Heffron S, Bergmann E.

Cell. 1990 Feb 23;60(4):525-8. Review. No abstract available.

PMID:
2105846
44.

Characterization of precrystallization aggregation of canavalin by dynamic light scattering.

Kadima W, McPherson A, Dunn MF, Jurnak FA.

Biophys J. 1990 Jan;57(1):125-32.

45.

Preliminary crystallographic analysis of a plant pathogenic factor: pectate lyase.

Kim CY, Mosser V, Keen N, Jurnak F.

J Mol Biol. 1989 Jul 20;208(2):365-7.

PMID:
2769765
46.

Preparation of Escherichia coli elongation factor Tu-guanosine 5'-triphosphate analogs.

Delaria K, Jurnak F.

Anal Biochem. 1989 Feb 15;177(1):188-93.

PMID:
2662816
47.

The three-dimensional structure of c-H-ras p21: implications for oncogene and G protein studies.

Jurnak F.

Trends Biochem Sci. 1988 Jun;13(6):195-8. No abstract available. Erratum in: Trends Biochem Sci 1988 Oct;13(10):397.

PMID:
3151222
48.

Molecular approaches towards an anti-ras drug.

Sigal IS, Smith GM, Jurnak F, Marsico-Ahern JD, D'Alonzo JS, Scolnick EM, Gibbs JB.

Anticancer Drug Des. 1987 Oct;2(2):107-15. Review.

PMID:
3130069
49.

Preliminary X-ray diffraction analysis of crystals of Bacillus thuringiensis toxin, a cell membrane disrupting protein.

McPherson A, Jurnak F, Singh GJ, Gill SS.

J Mol Biol. 1987 Jun 5;195(3):755-7.

PMID:
3656433
50.

Supplemental Content

Loading ...
Support Center